Episode Details

Back to Episodes
GLP-1s as Longevity Drugs, Private Equity in 401Ks, Age in Place for 1500 Dollars 2-24-26

GLP-1s as Longevity Drugs, Private Equity in 401Ks, Age in Place for 1500 Dollars 2-24-26

Season 4 Episode 6 Published 7 months, 4 weeks ago
Description

Our News for the Ages by Rethinking Aging Club, February 24, 2026 episode.  Ellen Khalifa discussed the potential of GLP-1 drugs as longevity drugs. Benjamin Surmi addressed the shift of 401(k) investments into private equity, emphasizing the complexities and regulatory changes involved. Elizabeth Magallon Fleury shared practical aging-in-place modifications, such as better lighting, staircase rails, and raised toilet seats, costing under $1,500. The importance of proactive measures and mindfulness in preventing falls was also emphasized.

Presented by Ellen Khalifa, Habits Coach for Healthspan and Wellspan 
Nature Biotechnology 11-12-25 Are GLP-1s the First Longevity Drugs?
https://www.nature.com/articles/s41587-025-02932-1

Mentioned GLP-1 Women’s Health session at CES 2026 (video) 

Presented by Benjamin Surmi, Senior Living Expert and Social Gerontologist
Financial Advisor Mag The 401(k) Takeover: Private Equity Muscles In On Retirement by Loukia Gyftopoulou
https://www.fa-mag.com/news/the-401-k--takeover--private-equity-muscles-in-on-retirement-85914.html

Presented by Elizabeth Magallon Fleury, CAPS, Life's Encore Planning  featuring Carol Chiang, How to Set Up Your Home to Age in Place for $1,500 by Veronica Dagher
https://www.wsj.com/personal-finance/how-to-set-up-your-home-to-age-in-place-for-1-500-9a3508bf
Apple access: https://apple.news/Ajd0T6T8wRYqQpIQV_CsjoA

Discussion hosted with commentary by: Linda Sherman and Ray Gordon

BoomerTechTalk.com episode page 

2-24-26 LinkedIn Show Post

News for the Ages podcasts live on Tuesdays. How to join live.

Please follow both of our podcasts including Rethinking Aging Club Podcast.

Nickie’s Tune written and performed by Richard Sherman

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us